Kavar Capital Partners Group’s Amgen AMGN Stock Holding History

Kavar Capital Partners Group’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$394K	Buy	1,087 +24	+2%	+$8.22K	0.05%	144
2026 Q1	$374K	Buy	1,063 +7	+0.7%	+$2.5K	0.05%	152
2025 Q4	$346K	Buy	1,056 +6	+0.6%	+$1.9K	0.05%	140
2025 Q3	$296K	Sell	1,050 -6	-0.6%	-$1.74K	0.04%	155
2025 Q2	$295K	Hold	1,056	–	–	0.04%	155
2025 Q1	$329K	Buy	1,056 +6	+0.6%	+$1.77K	0.05%	133
2024 Q4	$274K	Hold	1,050	–	–	0.05%	144
2024 Q3	$338K	Hold	1,050	–	–	0.05%	136
2024 Q2	$328K	Hold	1,050	–	–	0.06%	126
2024 Q1	$299K	Buy	+1,050	New	+$307K	0.06%	133
2021 Q3	–	Sell	-840	Closed	-$205K	–	173
2021 Q2	$205K	Buy	+840	New	+$207K	0.05%	144
2019 Q3	–	Sell	-440	Closed	-$81K	–	146
2019 Q2	$81K	Buy	+440	New	+$78.8K	0.03%	179
2018 Q3	–	Sell	-440	Closed	-$81K	–	110
2018 Q2	$81K	Hold	440	–	–	0.04%	152
2018 Q1	$75K	Buy	+440	New	+$80.8K	0.04%	158
2016 Q1	–	Sell	-32	Closed	-$5K	–	107
2015 Q4	$5K	Hold	32	–	–	﹤0.01%	294
2015 Q3	$4K	Sell	32 -8	-20%	-$1.26K	﹤0.01%	314
2015 Q2	$6K	Buy	+40	New	+$6.41K	﹤0.01%	319

Other funds holding AMGN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Kavar Capital Partners Group's AMGN Position: Q2 2026 in Review

Kavar Capital Partners Group increased its Amgen (AMGN) stake by 2.3% in Q2 2026, buying an estimated $8.22K and bringing the position to 1,087 shares worth $394K. The position accounts for 0.05% of the portfolio, ranked #144.

Kavar Capital Partners Group first reported a position in AMGN in Q2 2015 and has held it in 17 quarters since. 3,139 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

Kavar Capital Partners Group held 1,087 shares of Amgen worth $394K as of Q2 2026.
Kavar Capital Partners Group bought 24 Amgen shares in Q2 2026, an estimated $8.22K.
Amgen made up 0.05% of Kavar Capital Partners Group's portfolio in Q2 2026, its #144 holding.
Kavar Capital Partners Group first reported a position in Amgen in Q2 2015 and has held it in 17 quarters since.
3,139 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Kavar Capital Partners Group's 13F filing for Q2 2026, filed 20 Jul 2026.